Cancer Genetics – News and Features

Researchers have identified a molecular pathway responsible for glioblastoma spreading within in the brain, and an existing drug that may curb tumor growth, leading to a clinical trial that could offer new hope to patients with glioblastoma.

Researchers believe they have identified a cell signaling pathway responsible for the development of an aggressive and increasingly common form of esophageal cancer, which could potentially be used as a therapeutic target.

Researchers have identified that the gene responsible for glioblastoma also drives the development of soft tissue cancers in children.

Physician-scientists have discovered that a gene called FOXR2 that is normally turned off in most tissues in the body is activated in at least 70 percent of cancer types and eight percent of all individual tumors.

Researchers have discovered that cancer cells produce their own unique form of collagen that protects against immune responses. The abnormal collagen is fundamentally different from normal collagen, providing a highly specific target for therapy.

After many studies, The International Agency for Research on Cancer has classified occupational exposure as a firefighter as carcinogenic.

Scientists from seven research institutions have used pioneering bioinformatic modeling to investigate the molecular interactions of the p53 protein known to give protection against cancers.

According to research, leukocyte cell-derived chemotaxin 2 is an important liver-secreted hepatokine for virus elimination.

Study provides key insights toward a possible treatment for pancreatic ductal adenocarcinoma that can block the spread of the disease to other organs.

Researchers have developed a novel, automated liquid biopsy test prototype, designed to detect cancer DNA in the blood of patients with advanced metastatic breast cancer within five hours.